[ 1 ] IMDRF SaMD Working Group. Software as a Medical Device (SaMD): Key definitions [C].Washington D.C.: IMDRF, 2013.

[ 2 ] Matheny M E, Whicher D, Israni S T. Artificial intelligence in health care: A report from the National Academy of Medicine [J]. The Journal of the American Medical Association, 2020, 323:509– 510. 链接1

[ 3 ] Benjamens S, Dhunnoo P，Meskó B. The state of artificial intelligence-based FDA-approved medical devices and algorithms: An online database [J]. npj Digital Medicine, 2020, 3(1): 118. 链接1

[ 4 ] European Commission. ATI - Artificial Intelligence-based software as a medical device [R]. Brussels: European Commission, 2020.

[ 5 ] FDA. Proposed regulatory framework for modifications to Artificial Intelligence/ Machine Learning (AI/ML)—Based Software as a Medical Device (SaMD) [R]. Silver Spring: FDA, 2019.

[ 6 ] IMDRF. Software as a Medical Device: Possible framework for risk categorization and corresponding considerations [C]. Washington D.C.: IMDRF, 2014.

[ 7 ] Abràmoff M D, Lavin P T, Birch M, et al. Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care offices [J]. npj Digital Medicine, 2018, 1: 39. 链接1

[ 8 ] 严舒, 徐东紫, 欧阳昭连. 美国人工智能医疗器械监管与应用分 析 [J]. 中国医疗设备 2021, 36(2): 117–122. Yan S, Xu D Z, Ouyang Z L. Analysis on the regulation and Application of United States Intelligence medical device [J]. China Medical Devices, 2021, 36(2): 117–122.
Yan S, Xu D Z, Ouyang Z L. Analysis on the regulation and Application of United States Intelligence medical device [J]. China Medical Devices, 2021, 36(2): 117–122. Chinese. 链接1

[ 9 ] FDA. How is the FDA considering regulation of Artificial Intelligence and machine learning medical devices?[R/OL]. (2021-09-21)[2021-11-10]. https://www.fda.gov/medical-devices/ software-medical-device-samd/artificial-intelligence-andmachine-learning-software-medical-device#regulation.
FDA. How is the FDA considering regulation of Artificial Intelligence and machine learning medical devices? [R/OL]. (2021-09-21)[2021-11-10]. 链接1

[10] 国家药品监督管理局. 人工智能医用软件产品分类界定指导原 则 [R]. 北京：国家药品监督管理局, 2021. National Medical Products Administration. Guiding principles for the classification and definition of Artificial Intelligence medical software products [R]. Beijing: National Medical Products Administration, 2021.
National Medical Products Administration. Guiding principles for the classification and definition of Artificial Intelligence medical software products [R]. Beijing: National Medical Products Administration, 2021. Chinese.

[11] 国家药品监督管理局. 监管科学研究稳步推进 重点项目攻关成 果丰硕 [N]. 中国医药报, 2021-04-15(002). National Medical Products Administration. Scientific regulatory research has steadily made fruitful results in key projects [N]. China Medical News, 2021-04-15(002).
National Medical Products Administration. Scientific regulatory research has steadily made fruitful results in key projects [N]. China Medical News, 2021-04-15(002). Chinese.

[12] 赵飞, 高明献, 刘璞, 等. 136例国际医疗器械严重不良事件的统 计与分析 [J].中国医疗器械杂志, 2020, 44(2):166–171. Zhao F, Gao M X, Liu P, et al. Statistics and analysis of 136 cases of adverse events of international medical devices [J]. Chinese Journal of Medical Instrumentation, 2020, 44 (2): 166–171.
Zhao F, Gao M X, Liu P, et al. Statistics and analysis of 136 cases of adverse events of international medical devices [J]. Chinese Journal of Medical Instrumentation, 2020, 44 (2): 166–171. Chinese. 链接1

[13] 蔡小舒, 吕晖, 于广军. 美国FDA医疗人工智能软件审核指南研 究 [J].中国数字医学, 2019, 14(11): 34–37, 33. Cai X S, Lyu H,Yu G J. Study on audit guidelines of US FDA medical Artificial Intelligence software [J].China Digital Medicine, 2019, 14(11): 34–37, 33.
Cai X S, Lyu H, Yu G J. Study on audit guidelines of US FDA medical Artificial Intelligence software [J]. China Digital Medicine, 2019, 14(11): 34–37, 33. Chinese. 链接1

[14] Ministry of Health, Labour and Welfare (MHLW). Update on medical device and IVD regulation in Japan [R/OL].(2021-03-20) [2021-11-10]. https://www.pmda.go.jp/files/000234056.pdf.
Ministry of Health, Labour and Welfare (MHLW). Update on medical device and IVD regulation in Japan [R/OL]. (2021-03-20) [2021-11-10]. 链接1

[15] FDA. Artificial Intelligence/Machine Learning(AI/ML)-Based Software as a Medical Device(SaMD) action plan[R/OL]. (2021-01-15)[2021-11-10].https://www.fda.gov/media/145022/ download. 链接1

[16] ITU.Whitepaper for the ITU/WHO focus group on Artificial Intelligence for health [EB/OL]. (2020-10-13)[2021-11-10]. https:// www.itu.int/go/fgai4h.
ITU. Whitepaper for the ITU/WHO focus group on Artificial Intelligence for health [EB/OL]. (2020-10-13)[2021-11-10]. 链接1

[17] AI4EU.Verifiable and explainable risk forecasting Artificial Intelligence framework [EB/OL].（2021-11-26）[2021-11-28]. https://www.ai4europe.eu/business-and-industry/healthcare.
AI4EU.Verifiable and explainable risk forecasting Artificial Intelligence framework [EB/OL]. (2021-11-26)[2021-11-28]. 链接1

[18] National Institutes for Food and Drug Control. The kick-off meeting of the “Development and application demonstration of the full life cycle testing platform for medical Artificial Intelligence products” was held online[EB/OL].（2020-08-03）[2021-11-10]. https:// www.nifdc. org.cn/nifdc/gzdt/ywdt/20200803095421924.html.
National Institutes for Food and Drug Control. The kick-off meeting of the “Development and application demonstration of the full life cycle testing platform for medical Artificial Intelligence products” was held online [EB/OL]. (2020-08-03)[2021-11-10]. 链接1

[19] Wang Z F, Huang X L, Yang J，et al. Universal adversarial perturbation generated by attacking layer-wise relevance propagation [C]. New Yok: IEEE, 2020: 431–436.

[20] 王士泉，李言生，苏明亮，等. 医疗人工智能产品应用效果的评 估框架与流程研究 [J]. 医疗卫生装备, 2020, 41(1): 62–65. Wang S Q, Li Y S, Su M L, et al. Medical Artificial Intelligence product application evaluation framework and process research [J]. Chinese Medical Equipment Journal, 2020, 41(1): 62–65.
Wang S Q, Li Y S, Su M L, et al. Medical Artificial Intelligence product application evaluation framework and process research [J]. Chinese Medical Equipment Journal, 2020, 41(1): 62–65. Chinese. 链接1